9 unknown. 9 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Unknown 9 |
| Phase 2 | 8 | Unknown 8 |
Follow Thalassemia: new trials by email Literature Review of Thalassemia trials Research Report on Thalassemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children | Phase 2 / Phase 3 | Unknown | Al-Neelain University | 100 | 2020-02-15 | 2020-01-28 |
| the Efficacy and Safety of Sugammadex in Children 0-2 Years Old Sugammadex - Anesthesia, Pediatric Cancer | Phase 2 / Phase 3 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 62 | 2018-11-15 | 2018-11-02 |
| PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders Sofosbuvir and Ledipasvir - HCV Infection, Beta Thalassemia Major | Phase 3 | Unknown | Ain Shams University | 24 | 2018-06-11 | 2023-03-06 |
| An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients Deferiprone - Beta Thalassemia Major | Phase 2 / Phase 3 | Unknown | Ain Shams University | 64 | 2014-07-01 | 2015-01-14 |
| Role of Vitamin C to Augment Iron Chelation With DFP or DFX Vitamin C, Defriprone, deferisarox, deferiprone , deferesarox - Vitamin c, Thalassemia Major | Phase 2 / Phase 3 | Unknown | Ain Shams University | 50 | 2014-04-01 | 2014-03-11 |
| Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. Hydroxyurea ,Epiao, hydroxyurea, blood transfusion - Thalassemia Intermedia | Phase 2 / Phase 3 | Unknown | Ain Shams University | 40 | 2012-06-01 | 2012-06-20 |
| Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload DFP (ferriprox) and deferasirox (ICL 670), DFP, DFO - Beta-thalassemia Major, Sickle Cell Disease | Phase 2 / Phase 3 | Unknown | Ain Shams University | 60 | 2012-02-01 | 2012-02-06 |
| Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients Zoledronic acid, Placebo - Beta-Thalassemia, Bone Marrow Transplantation | Phase 2 / Phase 3 | Unknown | Tehran University of Medical Sciences | 50 | 2009-11-01 | 2011-07-26 |
| Therapeutic Effects of Silymarin in Patients With B-thalassemia Major Silymarin (LEGALON), Placebo - Beta-thalassemia Major, Iron Overload | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 140 | 2009-03-01 | 2009-10-21 |
beta-Thalassemia (9) · Anemia, Sickle Cell (2) · Hepatitis C (1) · Hepatoblastoma (1) · Iron Overload (1) · Neoplasms (1)
Anemia (9) · Anemia, Hemolytic (9) · Anemia, Hemolytic, Congenital (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Hemoglobinopathies (9) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1)
Deferiprone (3) · Isoflurophate (2) · Ascorbic Acid (1) · Blood Transfusion (1) · Deferasirox (1) · Deferoxamine (1) · Gum Arabic (1) · Hydroxyurea (1) · Pectins (1) · Silymarin (1) · Sugammadex (1) · Zoledronic Acid (1) · ledipasvir, sofosbuvir drug combination (1)
Ain Shams University (5) · Al-Neelain University (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Isfahan University of Medical Sciences (1) · Tehran University of Medical Sciences (1)
Egypt (5) · Iran (2) · Russia (1) · Sudan (1)
Anna Konstantinova, MD (1) · Behjat Moayedi, Professor (1) · Imad M Fdl-Elmula, PhD (1) · Manal H El-Sayed, M.D (1) · Mohsen S Elalfy, professor (1) · Mohsen S Elalfy, professour (1) · Mohsen S. Elalfy, professour (1)
PMID 23927461, PMID 25600572, PMID 29119631, PMID 34186262, PMID 37975597